Comment on Proposed Restriction of PFAS --A citizen of the earth.

The Essentiality of PFAS for Rigid Gas Permeable Contact Lenses Dr Mark D Eddleston Summary The safety and effectiveness of rigid gas permeable (RGP) contact lenses is reliant on the use of PFAS.

AR226-2948 Performing Laboratory Haskell E.

SYNPUNKTER PA ANNEX XV BEGRANSNINGSFORSLAG PER- AND POLYFLUOROALKYL SUBSTANCES (PFAS) ALLMANT SOBEGRANSNINGSFORSLAGETS OMFATTNING --_ /ANVANDNING AV PFAS BLAND IKEM:S MEDLEMSFORETAG IKEM-- r E EEms s, i Ses msmpsin mmaetmebriraaln.

2nd submission - Comment on Proposed Restriction of PFAS Conference of Fluoro-Chemical Product Japan (FCJ) On behalf of chemical manufacturers, we, Conference of Fluoro-Chemical Product Japan (FCJ), have been working tirelessly to comply with national chemical regulations.

Based on our extensive experience with corrosion-resistant materials, we are not only competent in the design and manufacture of key process engineering components, but also have the in-house knowledge of processing these highly corrosive products, such as sulfuric acid, nitric acid and hydrochloric acid.

AR226-3385 Subchronic, Developmental, and Reproductive Toxic Fluoroalkylethyl Phosphate Surfactant J.C.

PHOTODEGRADATION TEST SUBSTANCE Identity:Perfluorooctanesulfonatmea;y alsobe referredto as PFOS or FC-95. (1-Octanesulfonicacid,1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8heptadecafluoro-p,otassium salt,CAS 2795-39-3) Remarks: Testingisinprogress.

ikAda

KION GROUP Page 1 KION GROUP do STILL S.p.A.

Registered Substances Name 1,2-dimethyl-3-butylimidazolium bis(trifluoromethanesulfonyl)imide 1,3-Dimethylimidazolium Bis(trifluoromethanesulfonyl)imide 1-(2-Hydroxyethyl)-3-methylimidazolium Bis(trifluoromethanesulfonyl)imide 1-(4-Sulfobutyl)-3-methylimidazolium bis(trifluoromethanesulfonyl)imide 1-Allyl-1-methylpyrrolidinium Bis(trifluoromethanesulfonyl)imide 1-Allyl-3H-imidazolium bis(trifluoromethanesulfonyl)imide 1-Butyl-1-methylpyrrolidinium Bis(trifluoromethanesulfonyl)imide 1-Butyl-3-methylimidazolium Bis(trifluoromethanesulfonyl)imide 1-Butyl-4-methylpyridinium Bis(trifluoromethanesulfonyl)imide 1-Butylpyridinium Bis(trifluoromethanesulfonyl)imide 1-Decyl-3-methylimidazolium bis(trifluoromethanesulfonyl)imide 1-Dodecyl-1-methylpyrrolidinium bis(trifluoromethanesulfonyl)imide 1-Dodecyl-3-methylimidazolium Bis(trifluoromethanesulfonyl)imide 1-Ethyl-2,3-dimethylimidazolium Bis(trifluoromethanesulfonyl)imide 1-Ethyl-3-methylpyridinium Bis(trifluoromethanesulfonyl)imide 1-Hexadecyl-1-methylpyrrolidinium bis(trifluoromethanesulfonyl)imide 1-Methyl-1-(2-methoxyethyl)pyrrolidinium bis(trifluoromethanesulfonyl)imide 1-Methyl-1-n-octylpyrrolidinium Bis(trifluoromethanesulfonyl)imide 1-Methyl-1-pentylpyrrolidinium Bis(trifluoromethanesulfonyl)imide 1-Methyl-1-propylpyrrolidinium Bis(trifluoromethanesulfonyl)imide 1-Methyl-3-n-octylimidazolium Bis(trifluoromethanesulfonyl)imide 1-Methyl-3-propylimidazolium Bis(trifluoromethanesulfonyl)imide 1-Methylimidazole Bis(trifluoromethanesulfonyl)imide 1-Methylpyridinium Bis(trifluoromethanesulfonyl)imide 1-Vinyl-3H-imidazolium bis(trifluoromethanesulfonyl)imide 3-Ethyl-1-vinylimidazolium Bis(trifluoromethanesulfonyl)imide Amyltriethylammonium Bis(trifluoromethanesulfonyl)imide Benzyl(ethyl)dimethylammonium Bis(trifluoromethanesulfonyl)imide Cyclohexyltrimethylammonium Bis(trifluoromethanesulfonyl)imide Cyclohexyltrimethylammonium Bis(trifluoromethanesulfonyl)imide Ethyl(2-methoxyethyl)dimethylammonium Bis(trifluoromethanesulfonyl)imide Ethyl(3-methoxypropyl)dimethylammonium Bis(trifluoromethanesulfonyl)imide Ethyl(dimethyl)(2-phenylethyl)ammonium Bis(trifluoromethanesulfonyl)imide H-methylimidazolium bis(trifluoromethanesulfonyl)imide N,N-dimethyl-N-ethyl-N-(3-methoxypropyl)ammonium bis(trifluoromethanesulfonyl)imide N-Trimethyl-N-propylammonium bis(trifluoromethanesulfonyl)imide Tributyl(2-methoxyethyl)phosphonium Bis(trifluoromethanesulfonyl)imide Tributylmethylphosphonium Bis(trifluoromethanesulfonyl)imide Triethylammonium bis(trifluoromethanesulfonyl)imide Triethylsulfonium Bis(trifluoromethanesulfonyl)imide 1,2-dimethyl-3-propyl imidazolium bis((trifluoromethyl)sulfonyl)amide 1-Allyl-3-methylimidazolium bis(trifluoromethylsulfonyl)imide 1-Butanaminium, N,N-dibutyl-N-methyl-, salt with 1,1,1-trifluoro-N-[(trifluoromethyl)sulfonyl]methanesulfonamide ( 1-Butyl-1-methylpiperidinium bis(trifluoromethylsulfonyl)imide 1-Hexyl-1-methylpyrrolidin-1-ium Bis((trifluoromethyl)sulfonyl)amide bis(trifluoromethylsulfonyl)azanide;1-ethyl-3-methylimidazol-3-ium Butyltrimethylammonium bis(trifluoromethylsulfonyl)imide Diethylmethyl-(2-methoxyethyl)ammonium bis(trifluoromethylsulfonyl)imide Hexyltrimethylammonium bis(trifluoromethylsulfonyl)imide Methyl-trioctylammonium bis(trifluoromethylsulfonyl)imide 1,2-Dimethyl-3-octylimidazolium trifluoromethanesulfonate 1-(fluorosulfonyl)-2,3-dimethyl-1H-imidazol-3-ium trifluoromethanesulfonate 1-Butyl-1-methylpyrrolidinium Trifluoromethanesulfonate 1-Butyl-2,3-dimethylimidazolium Trifluoromethanesulfonate 1-Butyl-3-methylpyridinium trifluoromethanesulfonate 1-Butyl-4-methylpyridinium trifluoromethanesulfonate 1-Butylpyridinium trifluoromethanesulfonate 1-Carbobenzoxy-3-methylimidazolium Trifluoromethanesulfonate 1-Dodecyl-3-methylimidazolium trifluoromethanesulfonate 1-Ethyl-3-methyl-1H-imidazol-3-ium trifluoromethanesulfonate 1-Ethyl-1-methylpyrrolidinium trifluoromethanesulfonate 1-Ethylimidazolium trifluoromethanesulfonate 1-Ethylpyridinium trifluoromethanesulfonate 1-Hexyl-3-methylimidazolium Trifluoromethanesulfonate 1-Hexylpyridinium trifluoromethanesulfonate 1-Methyl-1-propylpyrrolidinium trifluoromethanesulfonate 1-Methyl-1H-benzimidazol-3-ium Trifluoromethanesulfonate 1-Methyl-3-n-octylimidazolium Trifluoromethanesulfonate 1-Methylimidazole Trifluoromethanesulfonate 1-Phenyl-1H-imidazol-3-ium Trifluoromethanesulfonate 1H-Benzimidazol-3-ium Trifluoromethanesulfonate 1H-Imidazol-3-ium Trifluoromethanesulfonate 2-(benzyloxy)-1-methylpyridinium trifluoromethanesulfonate Ammonium trifluoromethanesulfonate Diethylmethylammonium trifluoromethanesulfonate Diphenylammonium Trifluoromethanesulfonate Methyltrioctylammonium trifluoromethanesulfonate METHYLTRIPHENOXYPHOSPHONIUM TRIFLUOROMETHANESULFONATE 1-Butyl-3-methylimidazolium trifluoromethansulfonate 1-Decyl-3-methylimidazolium triflate 1-Ethyl-2,3-dimethylimidazolium triflate Tetrabutylammonium, salt with trifluoromethylsulphonic acid (1:1) Tetraethylammonium trifluoromethanesulphonate Tetrapropylammonium trifluoromethanesulphonate EC / List Number 700-236-0 801-349-9 801-353-0 834-775-9 834-838-0 955-835-1 606-989-0 605-742-4 801-364-0 801-366-1 801-469-1 955-861-3 801-468-6 680-128-7 680-126-6 955-610-8 862-175-7 801-406-8 835-943-4 677-592-8 801-466-5 619-549-8 801-390-2 835-611-9 834-830-7 833-612-9 677-132-6 833-572-2 932-543-2 807-997-9 835-030-0 835-264-3 834-431-8 955-782-4 955-563-3 691-430-3 672-665-0 672-621-0 955-565-4 628-992-6 805-807-9 663-153-8 643-020-0 625-892-4 801-464-4 700-235-5 Cas Number 350493-08-2 174899-81-1 174899-86-6 909390-59-6 1059624-23-5 223437-11-4 174899-83-3 475681-62-0 187863-42-9 433337-23-6 404001-48-5 174899-90-2 841251-37-4 757240-24-7 927021-43-0 380497-17-6 223437-05-6 178631-04-4 216299-72-8 353239-08-4 742086-10-8 1013027-27-4 319476-28-3 906478-91-9 1186103-43-4 952155-74-7 557788-37-1 1373334-05-4 1804970-28-2 268536-05-6 959698-44-3 324575-10-2 321746-49-0 169051-76-7 655249-87-9 405514-94-5 623580-02-9 380497-19-8 174899-82-2 628-266-9 801-404-7 801-355-1 629-541-6 801-352-5 845-920-0 663-158-5 801-455-5 801-449-2 801-448-7 801-450-8 691-474-3 801-416-2 680-002-1 801-441-9 801-309-0 801-358-8 628-457-7 801-451-3 801-437-7 878-801-7 627-928-4 801-387-6 878-891-8 881-473-8 627-698-5 626-181-1 629-264-0 807-362-6 679-776-3 801-402-6 667-942-8 678-094-3 801-459-7 623-746-4 252-783-5 252-781-4 252-792-4 258273-75-5 464927-84-2 210230-43-6 375395-33-8 865606-94-6 2179072-33-2 367522-96-1 765910-73-4 857841-32-8 882172-79-4 390423-43-5 163080-99-7 404001-52-1 145022-44-2 893443-18-0 501693-46-5 3878-80-6 460345-16-8 623167-81-7 1224852-54-3 361447-89-4 403842-84-2 99257-94-0 361447-81-6 99257-95-1 29727-06-8 882980-43-0 38542-94-8 945715-39-9 164411-06-7 121107-18-4 58973-90-3 174899-66-2 412009-62-2 174899-72-0 35895-70-6 35895-69-3 35925-48-5 Substance Information Page https://echa.europa.eu/de/substance-information/-/substanceinfo/100.148.976 https://echa.europa.eu/de/substance-information/-/substanceinfo/100.227.994 https://echa.europa.eu/de/substance-information/-/substanceinfo/100.227.997 https://echa.europa.eu/de/substance-information/-/substanceinfo/100.270.787 https://echa.europa.eu/de/substance-information/-/substanceinfo/100.270.843 https://echa.europa.eu/de/substance-information/-/substanceinfo/100.356.035 https://echa.europa.eu/de/substance-information/-/substanceinfo/100.109.496 https://echa.europa.eu/de/substance-information/-/substanceinfo/100.109.437 https://echa.europa.eu/de/substance-information/-/substanceinfo/100.228.007 https://echa.europa.eu/de/substance-information/-/substanceinfo/100.228.009 https://echa.europa.eu/de/substance-information/-/substanceinfo/100.228.103 https://echa.europa.eu/de/substance-information/-/substanceinfo/100.356.191 https://echa.europa.eu/de/substance-information/-/substanceinfo/100.228.102 https://echa.europa.eu/de/substance-information/-/substanceinfo/100.205.060 https://echa.europa.eu/de/substance-information/-/substanceinfo/100.205.058 https://echa.europa.eu/de/substance-information/-/substanceinfo/100.354.171 https://echa.europa.eu/de/substance-information/-/substanceinfo/100.314.061 https://echa.europa.eu/de/substance-information/-/substanceinfo/100.228.046 https://echa.europa.eu/de/substance-information/-/substanceinfo/100.271.978 https://echa.europa.eu/de/substance-information/-/substanceinfo/100.202.711 https://echa.europa.eu/de/substance-information/-/substanceinfo/100.228.100 https://echa.europa.eu/de/substance-information/-/substanceinfo/100.129.282 https://echa.europa.eu/de/substance-information/-/substanceinfo/100.228.031 https://echa.europa.eu/de/substance-information/-/substanceinfo/100.271.646 https://echa.europa.eu/de/substance-information/-/substanceinfo/100.270.836 https://echa.europa.eu/de/substance-information/-/substanceinfo/100.269.479 https://echa.europa.eu/de/substance-information/-/substanceinfo/100.202.288 https://echa.europa.eu/de/substance-information/-/substanceinfo/100.269.443 https://echa.europa.eu/de/substance-information/-/substanceinfo/100.171.158 https://echa.europa.eu/de/substance-information/-/substanceinfo/100.235.921 https://echa.europa.eu/de/substance-information/-/substanceinfo/100.271.049 https://echa.europa.eu/de/substance-information/-/substanceinfo/100.271.283 https://echa.europa.eu/de/substance-information/-/substanceinfo/100.270.421 https://echa.europa.eu/de/substance-information/-/substanceinfo/100.355.713 https://echa.europa.eu/de/substance-information/-/substanceinfo/100.353.824 https://echa.europa.eu/de/substance-information/-/substanceinfo/100.219.096 https://echa.europa.eu/de/substance-information/-/substanceinfo/100.198.196 https://echa.europa.eu/de/substance-information/-/substanceinfo/100.198.156 https://echa.europa.eu/de/substance-information/-/substanceinfo/100.353.888 https://echa.europa.eu/de/substance-information/-/substanceinfo/100.157.214 https://echa.europa.eu/de/substance-information/-/substanceinfo/100.232.799 https://echa.e

1 Introduction MTU Maintenance Berlin-Brandenburg GmbH (MTU) provides its services to sectors with very stringent regulatory obligations.

Fluororesin Products for PFA lined ball valve, Insertion pipe, safety valve, pressure gauze, gasket, and etc. for use of transportation of chemical solution in semiconductor devise and liquid crystal factory.

AnimalhealthEurope Contribution to the consultation of the Annex XV restriction dossier for per- and polyfluoroalkyl substances (PFAS) Information in support of a time-unlimited derogation of veterinary active substances from the universal PFAS-restriction Addendum to Submission 5390 SOCIO-ECONOMIC ANALYSIS Of the potential restriction of the per- and polyfluoroalkyl substances (PFAS) used in the production of veterinary medicines The viewpoint of the manufacturers of veterinary medicines As prepared by EPPA SA/NV 1 Information in support of a time-unlimited derogation of veterinary active substances from the universal PFAS-restriction Table of Contents 1 About AnimalhealthEurope ............................................................................................................ 3 2 Executive summary ......................................................................................................................... 3 3 Introduction .................................................................................................................................... 4 4 Tonnages used and emissions of veterinary APIs ........................................................................... 4 5 Data requirements under sectoral legislation Reg. 2019/6............................................................ 5 6 The connection between animal and human health ...................................................................... 5 7 Companion animal parasiticides ..................................................................................................... 6 7.1 Definition and importance of parasites in animal health ....................................................... 6 7.2 Are ectoparasitoses and vector borne diseases common in animals and humans?